What is Dianthus Therapeutics's other income (expense)?

Dianthus Therapeutics (DNTH) reported other income (expense) of $5.7M in Q1 2026.

How has Dianthus Therapeutics's other income (expense) changed year-over-year?

Dianthus Therapeutics's other income (expense) increased by 55.5% year-over-year, from $3.67M to $5.7M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Dianthus Therapeutics DNTH Other Income (Expense)

Other Income (Expense) at other companies

AmgenAMGN

$75M-95.1%

Spyre Therapeutics, Inc.SYRE

-$23.36M-366%

Kymera TherapeuticsKYMR

$14.92M+68.7%

Protagonist TherapeuticsPTGX

$53K-35.4%

TG TherapeuticsTGTX

-$14.43M-358%

Immunovant, Inc.IMVT

$798K-25.5%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's other income (expense)?: Dianthus Therapeutics (DNTH) reported other income (expense) of $5.7M in Q1 2026.
How has Dianthus Therapeutics's other income (expense) changed year-over-year?: Dianthus Therapeutics's other income (expense) increased by 55.5% year-over-year, from $3.67M to $5.7M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.